Will Blenrep receive FDA approval by end of 2024? | Binary | | | 7 months ago | |
Competitor response to Blenrep trial results by end of 2024 | Categorical | | | 7 months ago | |
EMA decision on Blenrep by end of 2024 | Categorical | | | 7 months ago | |
Will GSK stock price increase by end of 2024? | Binary | | | 7 months ago | |
New Scientific Studies Linking Zantac to Cancer by Mid-2025? | Binary | | | 7 months ago | |
Outcome of Next Major Zantac-Related Lawsuit | Categorical | | | 7 months ago | |
Zantac Reintroduction to Market by End of 2024? | Binary | | | 7 months ago | |
Competitor Responses to GSK Asthma Drug by 2024 | Categorical | | | 7 months ago | |
First Market Approval for GSK Asthma Drug by End of 2025 | Categorical | | | 7 months ago | |
GSK Asthma Drug FDA Approval by Mid-2025? | Binary | | | 7 months ago | |
GSK Drug Exceeds £3 Billion in First-Year Sales? | Binary | | | 7 months ago | |
GSK COVID-19 Vaccine FDA Approval by End of 2024? | Binary | | | 6 months ago | |
Will Blenrep return to the market by mid-2025? | Binary | | | 7 months ago | |
Blenrep market share by end of 2025 | Categorical | | | 7 months ago | |
Number of Zantac Lawsuits Settled in Favor of Plaintiffs by 2024 | Categorical | | | 7 months ago | |
Majority Zantac Lawsuit Wins by GSK and Boehringer in 2024? | Binary | | | 7 months ago | |
Real-World Clinical Outcomes of GSK Asthma Drug | Categorical | | | 7 months ago | |
GSK Asthma Drug UK Approval by 2024? | Binary | | | 7 months ago | |
Will EMA approve Pfizer's RSV vaccine ABRYSVO® for adults 18-59 by June 30, 2025? | Binary | | | 2 months ago | |
Will CDC recommend Pfizer's RSV vaccine ABRYSVO® for adults 18-59 by March 31, 2025? | Binary | | | 2 months ago | |
GSK share price to increase by over 10% by Dec 31, 2024, post-settlement? | Binary | | | 2 months ago | |
Regulatory body to impose additional fines on GSK for Zantac by end of 2025? | Categorical | | | 2 months ago | |
GSK to finalize Zantac settlement with all plaintiffs by June 30, 2025? | Binary | | | 2 months ago | |
Pharma company with most Zantac lawsuits by end of 2025? | Categorical | | | 2 months ago | |
GSK to face new significant Zantac lawsuits by end of 2025? | Binary | | | 2 months ago | |
Final settlement amount GSK pays for Zantac lawsuits by end of 2025? | Categorical | | | 2 months ago | |
What percentage of Zantac cases will GSK have settled by June 30, 2025? | Categorical | | | 2 months ago | |
Will GSK finalize Zantac settlement agreements by June 30, 2025? | Binary | | | 2 months ago | |
Will GSK's stock price increase by 10% or more by December 31, 2024? | Binary | | | 2 months ago | |
Will GSK win at least three more Zantac-related court cases by the end of 2024? | Binary | | | 5 months ago | |
Will GSK reach a settlement in any Zantac-related lawsuit by the end of 2024? | Binary | | | 5 months ago | |
GSK Influenza Vaccine FDA Approval by End of 2024? | Binary | | | 6 months ago | |
GSK COVID-19 Vaccine Phase 3 Trials Start by Mid-2024? | Binary | | | 6 months ago | |
Stock Price Impact on GSK and Boehringer Post-Zantac Lawsuits by 2024 | Categorical | | | 7 months ago | |
Will Pfizer's RSV vaccine ABRYSVO® capture more than 50% market share in the US for adults 18-59 by end of 2025? | Binary | | | 2 months ago | |
How many doses of Pfizer's RSV vaccine ABRYSVO® will be administered to US adults 18-59 by end of 2025? | Categorical | | | 2 months ago | |
Which country will first approve Pfizer's RSV vaccine ABRYSVO® for adults 18-59 outside the US by June 30, 2025? | Categorical | | | 2 months ago | |
Which company will have the largest market share in RSV vaccines for US adults 18-59 by end of 2025? | Categorical | | | 2 months ago | |
What will be GSK's total financial impact from Zantac settlements by end of 2025? | Categorical | | | 2 months ago | |
Will GSK face new legal actions related to Zantac by December 31, 2024? | Binary | | | 2 months ago | |
How will Zantac settlements affect GSK's 2024 annual revenue? | Categorical | | | 2 months ago | |
What will be the outcome of the next Zantac-related court case for GSK? | Categorical | | | 5 months ago | |
How many Zantac-related lawsuits will GSK win by the end of 2024? | Categorical | | | 5 months ago | |
Which state will see the next Zantac-related court case against GSK? | Categorical | | | 5 months ago | |
Will any new scientific study in 2024 find a link between ranitidine and cancer? | Binary | | | 5 months ago | |
GSK New COVID-19 Vaccine Sales in 2025 | Categorical | | | 6 months ago | |
GSK New Influenza Vaccine Sales in 2025 | Categorical | | | 6 months ago | |
First Major Market to Approve GSK COVID-19 Vaccine by End of 2024 | Categorical | | | 6 months ago | |